Segment Information (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Reportable Segment Information

	Three Months Ended
	March 31,
(DOLLARS IN MILLIONS)	2021		2020
Net sales:
Nourish	$	1,308	$	772
Health & Biosciences	426		34
Scent	569		541
Pharma Solutions	162		—
Consolidated	$	2,465	$	1,347
Segment Adjusted Operating EBITDA
Nourish	$	270	$	176
Health & Biosciences	128		9
Scent	128		118
Pharma Solutions	43		—
Total	569		303
Depreciation & Amortization	(242)		(81)
Interest Expense	(65)		(32)
Other Income (Expense), net	7		(11)
Frutarom Integration Related Costs (a)	(1)		(4)
Restructuring and Other Charges, net (b)	(4)		(5)
Losses on sale of assets	—		(1)
Shareholder Activism Related Costs (c)	(7)		—
Employee Separation Costs (d)	(3)		—
Compliance Review & Legal Defense Costs (e)	—		(1)
N&B Inventory Step-Up Costs	(182)		—
N&B Transaction Related Costs (f)	(89)		(5)
N&B Integration Related Costs (g)	(37)		(10)
(Loss) Income Before Taxes	$	(54)	$	153

_______________________

(a)	Represents costs related to the integration of the Frutarom acquisition. For 2021, costs primarily related to performance stock awards. For 2020, costs primarily related to advisory services, retention bonuses and performance stock awards.
(b)	For 2021, represents costs primarily related to severance as part of the Company's restructuring efforts. For 2020, represents costs primarily related to the Frutarom Integration Initiative.
(c)	Represents shareholder activist related costs, primarily professional fees.
(d)	Represents costs related to severance liabilities, including accelerated stock compensation expense, for employees who have separated from the Company.
(e)	Costs related to reviewing the nature of inappropriate payments and review of compliance in certain other countries. In addition, includes legal costs for related shareholder lawsuits.
(f)	Represents transaction costs and expenses related to the transaction with N&B, primarily includes legal and professional fees.
(g)	Represents costs primarily related to advisory services for the integration of the transaction with N&B, primarily consulting fees.

Net Sales by Destination of Product Delivery

Net sales, which are attributed to individual regions based upon the destination of product delivery, were as follows:

	Three Months Ended March 31,
(DOLLARS IN MILLIONS)	2021		2020
Europe, Africa and Middle East	$	873	$	543
Greater Asia	587		310
North America	722		303
Latin America	283		191
Consolidated	$	2,465	$	1,347

	Three Months Ended March 31,
(DOLLARS IN MILLIONS)	2021		2020
Net sales related to the U.S.	$	654	$	271
Net sales attributed to all foreign countries	1,811		1,076